Moderna Total Non-Operating Income/Expense 2017-2025 | MRNA

Moderna total non-operating income/expense for the twelve months ending March 31, 2025 was $323M, a 4.15% decline year-over-year.

  • Moderna annual total non-operating income/expense for 2024 was $0.338B, a 13.8% increase from 2023.
  • Moderna annual total non-operating income/expense for 2023 was $0.297B, a 91.61% increase from 2022.
  • Moderna annual total non-operating income/expense for 2022 was $0.155B, a 1509.09% decline from 2021.

Moderna Total Non-Operating Income/Expense 2017-2025 | MRNA

  • Moderna annual total non-operating income/expense for 2024 was $0.338B, a 13.8% increase from 2023.
  • Moderna annual total non-operating income/expense for 2023 was $0.297B, a 91.61% increase from 2022.
  • Moderna annual total non-operating income/expense for 2022 was $0.155B, a 1509.09% decline from 2021.